Keating, MKantarjian H, Gandhi V, OBrien S, Koller C, Kornblau S, Beran M, Andreeff M , Plunkett W, Freireich E
The readout is expected in the first half of 2026
Red Rock Peptides offers nationwide shipping for research-use materials
Review scope
Combining medication with a leading behavioral change engine to drive the adoption of healthy habits addresses patient demand
Wang et al.'s report provides valuable quantitative information for the efficacy of l-carnitine supplementation on glycemic control in T2DM patients ( In the present study, a total of 10 RCT studies comprising 1,239 T2DM patients were included for analysis, including 8 studies of l-carnitine ( In further analysis of the effects of l-carnitine on Body Mass in T2DM patients, we found the E max of l-carnitine on BMI in T2DM patients was 1.51% and the ET 50 of l-carnitine on BMI in T2DM patients was 0.5 weeks